ABOUT THIS EPISODE
How can biotech teams move faster (and smarter) from preclinical research to human trials without sacrificing safety or rigor?
In this episode, host Elaine Hamm, PhD, sits down with Todd Kilbaugh, MD, Founder of Pharos Biolabs and a physician-scientist specializing in anesthesiology, critical care, and pediatrics. Todd shares his journey from clinical medicine to biotech entrepreneurship and unpacks one of the industry’s toughest challenges: why so many promising therapies fail to translate from animal models to humans. Together, they explore how AI, advanced modeling, organoids, and more thoughtful use of non-human primates could reshape preclinical development and reduce costly failures.
In this episode, you’ll learn:
Tune in for a wide-ranging conversation on AI-enabled science, better trial prediction, and how biotech can rethink the path from discovery to patients.
Links:
Connect with Todd Kilbaugh, MD.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Doug Wallace, PhD.
Learn more about TBI.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
In this episode, host Elaine Hamm, PhD, sits down with Todd Kilbaugh, MD, Founder of Pharos Biolabs and a physician-scientist specializing in anesthesiology, critical care, and pediatrics. Todd shares his journey from clinical medicine to biotech entrepreneurship and unpacks one of the industry’s toughest challenges: why so many promising therapies fail to translate from animal models to humans. Together, they explore how AI, advanced modeling, organoids, and more thoughtful use of non-human primates could reshape preclinical development and reduce costly failures.
In this episode, you’ll learn:
- Why the translational gap between animal models and humans remains one of biotech’s biggest bottlenecks, and how AI can help close it.
- How biomarkers, mathematical modeling, and digital twins can improve trial design long before a therapy reaches the clinic.
- What the future of preclinical development could look like with smarter integration of AI, organoids, and non-human primate studies.
Tune in for a wide-ranging conversation on AI-enabled science, better trial prediction, and how biotech can rethink the path from discovery to patients.
Links:
Connect with Todd Kilbaugh, MD.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Doug Wallace, PhD.
Learn more about TBI.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors.
OTHER EPISODES IN THIS PODCAST
Have you ever left a conference with a stack of business cards… only to realize weeks later that you never followed up with the people you were most excited to meet?
In the final installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Za…
How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of …
Could family offices help biotech founders unlock new sources of capital in an increasingly challenging fundraising environment?
In this episode, host Elaine Hamm, PhD, sits down with Danielle Patterson, Executive Director of Family Office at ISS Market Intelligence, to explore the growing role of …
How can students start building a future in biotech before they even leave the lab?
In this episode, host Elaine Hamm, PhD, sits down with Haley Marcotte, Co-Managing Director of Nucleate New Orleans and a PhD student at Tulane University School of Medicine. Haley shares how discovering biotech as …
How do you turn a room full of strangers into meaningful professional relationships?
In the second installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Zanewicz, JD, LLM, RTTP, to discuss what happens after you've done the preparation…
Disclaimer: The podcast and artwork embedded on this page are from Elaine Hamm, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
